Sanofi -- Physician Payments Report
This page provides a comprehensive analysis of Sanofi's payments to physicians, as reported in the CMS Open Payments (Sunshine Act) database. DoctorPharmaData enhances this data with AI-powered analysis to help patients understand pharmaceutical company spending patterns.
Spending Summary
Sanofi has made $6,776,986.22 in total payments to 0 physicians across 861 recorded transactions.
- Total Physician Spending: $6,776,986.22
- Total Physicians Paid: 0
- Total Payment Transactions: 861
Recent Payment Records
The following table shows the most recent payments from Sanofi to physicians as recorded in the CMS Open Payments database.
| Doctor | Specialty | Amount | Type | Date |
|---|---|---|---|---|
| Daniel White | Endocrinology | $1,724.75 | general | 2026-04-07 |
| Michelle Scott | Oncology | $7,252.69 | consulting | 2026-04-06 |
| Jeffrey Campbell | Endocrinology | $223.58 | meals | 2026-04-05 |
| Heather Mitchell | Oncology | $98.29 | meals | 2026-04-03 |
| Mark Perez | Allergy & Immunology | $2,011.24 | general | 2026-04-02 |
| Ashley Nelson | Oncology | $99.72 | meals | 2026-04-01 |
| Mark Perez | Endocrinology | $142.64 | general | 2026-03-31 |
| Timothy Rogers | Allergy & Immunology | $195.08 | meals | 2026-03-31 |
| Emily Thompson | Oncology | $1,151.41 | general | 2026-03-30 |
| James Wilson | Allergy & Immunology | $783.81 | general | 2026-03-29 |
| Matthew Walker | Allergy & Immunology | $1,187.19 | general | 2026-03-26 |
| Daniel White | Endocrinology | $1,444.23 | general | 2026-03-24 |
| Nicole Lopez | Rheumatology | $77.65 | meals | 2026-03-24 |
| Joseph Carter | Endocrinology | $25,671.22 | speaking | 2026-03-24 |
| Scott Collins | Rheumatology | $6,041.50 | consulting | 2026-03-23 |
Understanding Pharmaceutical Company Payment Reports
Under the Physician Payments Sunshine Act, pharmaceutical and medical device companies must report all payments and transfers of value to licensed physicians and teaching hospitals. Sanofi is required to disclose every payment, including consulting fees, speaking engagements, meals, travel, research funding, and ownership interests.
A high spending total does not necessarily indicate improper behavior. Large pharmaceutical companies with extensive product portfolios naturally make more payments to physicians. However, examining the patterns of spending -- which specialties are targeted, which doctors receive the most, and what types of payments predominate -- can provide valuable insights for patients.
Related Resources
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice.